
How similar is your biosimilars?
Somru BioScience has developed an intelli.b™ platform for comparability testing of biologics? Biosimilars at molecular level that meets the intent of the FDA guidance for fingerprint-like analysis.
Read moreUltra-sensitive immunoassay solutions for
low-abundance biomarker and impurity detection

The rise of biosimilars has provided challenges and opportunities in equal measure for biotechnology, biopharmaceutical and bioanalytical contract research organizations (CROs). Somru BioScience has developed a portfolio of reagents, tools, solutions and a knowledge database that will enable companies to capitalize on biosimilar opportunities. We provide comprehensive expertise and solutions to reduce both the time and cost of your biosimilar development programs.
Read moreStay updated with the latest insights, research developments, and industry news from Somru BioScience. Explore our expert perspectives on biosimilars, immunogenicity, biomarker testing, and cutting-edge biopharmaceutical innovations.

Somru BioScience has developed an intelli.b™ platform for comparability testing of biologics? Biosimilars at molecular level that meets the intent of the FDA guidance for fingerprint-like analysis.
Read more
Somru BioScience offers high quality, sensitive and robust off-the-shelf ELISA kits for the measurement of anti-drug antibodies (i.e. both anti-innovator and anti-biosimilar) in biological matrices.
Read more
Biomarkers have become an integral part of the decision-making process not only in the personalized drug development process, but also in biosimilar and biobetter drug development.
Read moreExplore our comprehensive portfolio of biopharmaceutical products and solutions. From advanced antibody detection kits to cutting-edge biomarker assays, Somru BioScience provides the tools you need to accelerate your drug development and research programs.
Charlottetown, Prince Edward Island — June 2026 Somru BioScience Inc. is pleased to announce its participation in the BIO International Convention 2026 , taking place from June 22–25, 2026 , in San Di
We were delighted to welcome the Honourable Mélanie Joly Canada’s Minister of Industry, to Somru BioScience Inc. for a tour of our growing biomanufacturing facilities. It was an honour to showcase how
Somru BioScience Inc. and IdeAcT Limited hosted the Global Bioanalysis Workshop in Dhaka on December 17, 2025, focusing on bioanalysis, biologics, biosimilars, and vaccines. The event brought together industry experts and researchers to discuss regulatory requirements, analytical technologies, and best practices in biotherapeutic development.